Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
AC Immune SA
AC Immune SA
(ACIU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluorodopa f-18
prostatic neoplasms
Gilvetmab
neoplasms
,
skin neoplasms
,
melanoma
Bevifimod
healthy volunteers/patients
,
chronic renal insufficiency
,
drug delivery systems
,
hemostasis
,
prader-willi syndrome
,
hypercholesterolemia
,
leukemia
,
acute disease
,
blood coagulation disorders
,
hemostatic disorders
,
chronic kidney failure
,
rheumatoid arthritis
,
inflammation
,
depression
,
bipolar disorder
,
mood disorders
,
spinal muscular atrophy
,
spinal muscular atrophies of childhood
,
bone fractures
,
tibial fractures
,
noonan syndrome
,
growth disorders
,
hypoglycemia
,
hyperglycemia
,
asthma
,
chronic obstructive pulmonary disease
,
cystic fibrosis
,
wounds and injuries
,
diabetes mellitus
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
hemophilia a
,
laron syndrome
,
hemophilia b
,
pituitary dwarfism
,
inborn genetic diseases
,
obesity
,
turner syndrome
,
fatty liver
,
insulin resistance
,
atherosclerosis
,
arteriosclerosis
,
thrombasthenia
,
diabetic ketoacidosis
,
hemorrhage
,
postpartum hemorrhage
,
hypopituitarism
,
renal insufficiency
,
sepsis
,
respiratory insufficiency
,
surgical wound infection
,
diabetic neuropathies
,
gastrointestinal motility
,
dwarfism
,
achondroplasia
,
cardiovascular diseases
,
metabolic diseases
,
obstructive sleep apnea
,
non-alcoholic fatty liver disease
,
metabolic syndrome
,
overweight
Fludeoxyglucose f-18
idiopathic pulmonary fibrosis
,
healthy volunteers/patients
,
squamous cell carcinoma of head and neck
,
cardiovascular diseases
,
atherosclerosis
,
vascular diseases
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
stomach neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
esophageal squamous cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use